Iraq's biological weapons. The past as future?

Area of Science:

• Biosecurity and International Relations
• Biological Warfare Threat Assessment
• Weapons of Mass Destruction

Background:

• Iraq developed anthrax, botulinum toxin, and aflatoxin for biological warfare between 1985 and April 1991.
• Biological agents were deployed via 200 bombs and 25 ballistic missiles during Operation Desert Storm.
• The Iraqi biological warfare program posed a significant concern despite its limitations.

Purpose of the Study:

• To assess the military effectiveness of Iraq's biological warfare arsenal during the Persian Gulf War.
• To analyze the reasons for the probable ineffectiveness of Iraq's biological weapons.
• To discuss the ongoing threat of Iraq's biological warfare capability and recommend international responses.

Main Methods:

• Analysis of Iraq's biological warfare program data from 1985 to 1991.
• Evaluation of weapon deployment numbers and types.
• Assessment of military theater dominance and command/control capabilities of coalition forces.

Main Results:

• Iraq's biological warfare arsenal was likely militarily ineffective due to its small size, inefficient dispersal mechanisms, and coalition air superiority.
• Despite defeat in the Gulf War, the threat of Iraq's biological warfare capability persists.
• Saddam Hussein's continued desire for weapons of mass destruction remains a global security concern.

Conclusions:

• The international community must enforce UN resolutions to deter Iraq's reacquisition of biological warfare capabilities.
• A multidisciplinary approach is crucial for limiting future development of weapons of mass destruction.
• Continued vigilance and firm enforcement are necessary to mitigate the biological warfare threat posed by Iraq.